Defense Advanced Research Projects AgencyTagged Content List

Harness Biological Systems

Leveraging genetic technologies to engineer synthetic or natural organisms

Showing 9 results for Bio-systems + Med-Devices RSS
DARPA’s Biological Technologies Office develops capabilities that embrace the unique properties of biology—adaptation, replication, complexity—and applies those features to revolutionize how the United States defends the homeland and prepares and protects its Soldiers, Sailors, Airmen, and Marines. BTO is helping the Department of Defense to counter novel forms of bioterrorism, deploy innovative biological countermeasures to protect U.S. forces, and accelerate warfighter readiness and overmatch to confront adversary threats.
09/07/2017
DARPA published its Young Faculty Award (YFA) 2018 Research Announcement today, seeking proposals in 26 different topic areas—the largest number of YFA research areas ever solicited.
09/18/2017
DARPA has enjoyed a strong relationship with Silicon Valley since the early 1960s, working with innovators to lay the groundwork for new industries built around Agency investments in semiconductors, networking, artificial intelligence, user interfaces, programming, materials, microsystems, and more. Biotech is now emerging as a breakthrough opportunity space and it represents an area that is ripe for fresh collaboration among DARPA, the nation’s top researchers, venture capitalists, and entrepreneurs.
11/15/2019
In a twist on how gene editing technology might be applied in the future, DARPA’s newest biotechnology funding opportunity aims to incorporate gene editors into detectors for distributed health biosurveillance and rapid, point-of-need diagnostics for endemic, emerging, and engineered pathogenic threats. The “Detect It with Gene Editing Technologies” (DIGET) program could help the Department of Defense maintain force readiness by informing rapid medical response and increasing the standard of care for troops, and preserve geopolitical stability by preventing the spread of infectious disease from becoming a driver of conflict.
03/30/2020
We find ourselves in pandemic times. The global population is under siege by an infectious virus new to humankind. It’s called Severe Acute Respiratory Syndrome Coronavirus 2, or SARS-CoV-2. It’s the causative agent of the pandemic disease designated COVID-19. This viral adversary knows no politics. It recognizes no national boundaries. It is unconcerned with anyone’s identity. All 7.8 billion of us are the same to the virus: we are all hosts suitable to commandeer to make copies of itself.